Physician profile
Adam Sackstein
NPI 1396768081
$12,893.30
in general payments reported to CMS, 2019-2025
37 companies · $3,145 in 2025
The $3,145 reported for 2025 was more than what 86% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,218 · 2020: $587 · 2021: $854 · 2022: $895 · 2023: $3,959 · 2024: $2,234 · 2025: $3,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,053 · Travel and Lodging: $2,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,052.80 |
| Travel and Lodging | $2,285.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,121.08 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Anatomic Peek Ptc Cervical Fusion System |
| Nevro Corp. | $1,510.69 | 2019-2024 | Senza |
| Abbott Laboratories | $1,317.45 | 2019-2025 | Proclaim, Infinity, Octrode |
| Medtronic USA, INC. | $1,279.29 | 2019-2020 | |
| Globus Medical, INC. | $883.75 | 2025 | Senza, Vyrsa V1, Corridor |
| Stryker Corporation | $297.11 | 2025 | Mild Device Kit |
| Boston Scientific Corporation | $293.27 | 2020-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Si-Bone, INC. | $274.47 | 2020-2025 | |
| Relievant Medsystems, INC. | $241.59 | 2019-2022 | |
| Avanos Medical | $187.35 | 2019-2025 | Generator, Standard Rf Disposables |
| Foundation Fusion Solutions, LLC | $181.92 | 2024 | |
| Vertos Medical, INC. | $136.06 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $134.89 | 2022-2023 | Seglentis |
| Zynex Medical, INC. | $134.50 | 2025 | Nexwave |
| Vertiflex, INC. | $133.29 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $96.73 | 2024-2025 | Gel-One Cross-Linked Hyaluronate |
| Saluda Medical Americas, INC. | $93.08 | 2024-2025 | Evoke |
| Collegium Pharmaceutical, INC. | $92.77 | 2019-2025 | Belbuca |
| Janssen Pharmaceuticals, INC | $69.26 | 2023-2025 | Spravato |
| Grt US Holding, INC. | $53.86 | 2020-2021 | |
| Biotronik Nro, INC. | $47.15 | 2025 | Prospera |
| Depuy Synthes Sales INC. | $46.64 | 2019-2022 | |
| Bioventus LLC | $38.14 | 2022-2023 | Gelsyn-3 |
| Ibsa Pharma INC. | $32.57 | 2021-2025 | Flector, Tirosint, Licart |
| Conmed Corporation | $20.49 | 2025 | Airseal |
| Convatec INC. | $19.31 | 2024 | |
| Medline Industries LP | $18.56 | 2023 | |
| Valinor Pharma, LLC | $16.82 | 2025 | Movantik |
| Virtus Pharmaceuticals LLC | $16.00 | 2025 | Levorphanol Tartrate |
| Pacira Therapeutics, INC. | $14.70 | 2020 | |
| International Rehabilitative Sciences, INC | $14.60 | 2025 | Rs-4i Plus With Intersperse |
| Tersera Therapeutics LLC | $13.90 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $13.73 | 2023 | Iovera, Zilretta |
| Spr Therapeutics, INC | $13.52 | 2023 | Sprint Pns System |
| Daiichi Sankyo INC. | $12.40 | 2019 | |
| Pfizer INC. | $11.27 | 2019 | |
| Biodelivery Sciences International, INC. | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Sackstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.